Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 115 Cholangiocarcinoma 24 Carcinoma, Renal Cell 20 Liver Neoplasms 12 Stomach Neoplasms 10 Biliary Tract Neoplasms 10 Thyroid Neoplasms 8 Endometrial Neoplasms 8 Breast Neoplasms 8 Neoplasms 7 Recurrence 6 Neuroendocrine Tumors 5 Neoplasm Metastasis 5 Melanoma 5 Uterine Cervical Neoplasms 4 Thyroid Carcinoma, Anaplastic 4 Thyroid Cancer, Papillary 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Liver Diseases 3 Cirrhosis, Familial, with Pulmonary Hypertension 3 Carcinoma, Adenoid Cystic 3 Brain Neoplasms 3 Advanced Biliary Tract Cancer 3 Adenocarcinoma, Follicular 3 Adenocarcinoma 3 Uveal Melanoma 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Sarcoma 2

Interventions

Radiotherapy 9 Doxorubicin 7 pazopanib 5 palbociclib 4 Trabectedin 4 Gemcitabine 4 ribociclib 3 pembrolizumab 3 eribulin 3 Magnetic Resonance Spectroscopy 3 selinexor 2 liposomal doxorubicin 2 avelumab 2 abemaciclib 2 Sunitinib 2 Radiation Dose Hypofractionation 2 Radiation 2 Immunoglobulin G 2 Ifosfamide 2 Docetaxel 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 zimberelimab 1 temsirolimus 1 sotigalimab 1 sodium thiosulfate 1 sitravatinib 1 silmitasertib 1 sargramostim 1 romidepsin 1 regorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Liposarcoma × lenvatinib × Clear all

NCT03526679 2025-12-05

LEADER

National Taiwan University Hospital

Phase 1/2 Completed

30 enrolled 9 charts

Leiomyosarcoma, Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡